Andreas Straub

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

Elisabeth Perzborn, Andreas Wilmen, Jens Pohlmann et al. · Journal of Thrombosis and Haemostasis · 2005 · 583 citations · Full text

Molecular Pharmacology, Thrombosis, Vivo Studies +9

Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood

Stefanie Krajewski, Robert Prucek, Aleš Panáček et al. · Acta Biomaterialia · 2013 · 132 citations

Nanoparticles, Nanomedicine, Engineering +12

Evidence of Platelet Activation at Medically Used Hypothermia and Mechanistic Data Indicating ADP as a Key Mediator and Therapeutic Target

Andreas Straub, Stefanie Krajewski, Jan David Hohmann et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 82 citations · Full text

Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?

Jan David Hohmann, Xiaowei Wang, Stefanie Krajewski et al. · Blood · 2013 · 79 citations · Full text

Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia

Karlheinz Peter, Andreas Straub, Benedikt Köhler et al. · The American Journal of Cardiology · 1999 · 69 citations

Inflammation, Thrombosis, Thrombopoiesis +10